Clinical Trial

Adjunctive Methylene Blue in Septic Shock

Study acronym: BLUSH
Completed Phase 3
View on ClinicalTrials.gov →
Summary
Adjunctive Methylene BLUe in Septic SHock (BLUSH) is a single centre concealed-allocation parallel-group open-label randomized controlled pilot trial to ascertain the feasibility of a trial evaluating the efficacy and safety of adjunctive methylene blue infusion compared to usual care on outcomes of adult patients admitted to the intensive care unit with septic shock.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-26; most recent amendment 2026-03-18.
Status change: Recruiting → Completed 2026-03-18
Status change: Not Yet Recruiting → Recruiting 2025-06-03
Trial Details
NCT Number NCT06900140
Lead Sponsor Dr. Shannon M. Fernando
Conditions Septic Shock
Enrollment 50 participants
Start Date 2025-06-02
Primary Completion 2026-03-06 (estimated)
Study Completion 2026-03-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-19